You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Solid Tumor Cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Solid Tumor, Glioblastoma, NSCLC Trial in Nashville, Houston, Villejuif (TAS2940)

Recruiting
  • Solid Tumor
  • +3 more
  • Nashville, Tennessee
  • +2 more
Feb 25, 2022

Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica

Not yet recruiting
  • Pathologically Confirmed Cancer Refractory to Conventional Therapy
  • +7 more
  • SNK02
  • Santa Monica, California
    Sarcoma Oncology Center
Aug 10, 2023

Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

Recruiting
  • Cancer
  • +11 more
  • San Antonio, Texas
    South Texas Accelerated Research Therapeutics, LLC
Jun 21, 2023

Solid Tumor, Adult, Refractory Cancer Trial (GV20-0251)

Not yet recruiting
  • Solid Tumor, Adult
  • Refractory Cancer
  • (no location specified)
Dec 21, 2022

Advanced Solid Tumor Trial in Beijing (YK0901 cells)

Not yet recruiting
  • Advanced Solid Tumor
  • YK0901 cells
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023

Circulating Tumor Cells in Solid Tumors

Completed
  • Solid Tumor, Adult
  • Observational
  • Chapel Hill, North Carolina
    Radiation Oncology Clinic - UNC Cancer Hospital
Sep 27, 2022

Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor Trial in Australia, France, United States (BGB-A3055, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +2 more
  • Iowa City, Iowa
  • +7 more
Jul 5, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial in Nashville, Dallas, Fairfax (JZP898, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Nashville, Tennessee
  • +2 more
Oct 26, 2023

Advanced Solid Tumor Trial in Guangzhou (YL201 for Injection)

Recruiting
  • Advanced Solid Tumor
  • YL201 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 21, 2023

Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)

Recruiting
  • Solid Tumor
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital
Jun 14, 2023

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Sydney, New South Wales, Australia
    GenesisCare North Shore
Jun 16, 2023

Advanced Solid Tumor Trial in Boston (VAX014)

Not yet recruiting
  • Advanced Solid Tumor
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 2, 2023

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Solid Tumor Trial (Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T), Tumor necrosis factor-thymosin alfa 1 recombinant

Completed
  • Solid Tumor
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T)
  • Tumor necrosis factor-thymosin alfa 1 recombinant (TNF-T) and chemotherapy
  • (no location specified)
Jun 8, 2023

Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an

Recruiting
  • Metastatic Solid Tumor Cancer
  • Dose escalation, first-in-human phase I clinical trial with an Expansion phase
  • Caen, France
  • +2 more
Oct 11, 2022

s Recurrence and Response Via a Tumor Informed Assessment

Recruiting
  • Cancer
  • +4 more
  • Personalized Cancer Monitoring (PCM)
  • San Francisco, California
  • +1 more
Dec 5, 2022

Solid Tumor Trial in Houston (IMGS-001)

Recruiting
  • Solid Tumor
  • Houston, Texas
    MD Anderson Cancer Center
Aug 23, 2023

Advanced Solid Tumor Trial in China (BPI-460372)

Not yet recruiting
  • Advanced Solid Tumor
  • Beijing, Beijing, China
  • +3 more
Mar 16, 2023

Advanced Solid Tumor, Metastatic Solid Tumor, Lung Cancer Trial in Seoul, Incheon (WM-A1-3389, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • +7 more
  • WM-A1-3389
  • Pembrolizumab
  • Seoul, Seocho-gu, Korea, Republic of
  • +1 more
May 14, 2023

Patients With Advanced Solid Tumors Trial in Beijing (TCC1727 tablet)

Not yet recruiting
  • Patients With Advanced Solid Tumors
  • TCC1727 tablet
  • Beijing, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Jul 23, 2023

Solid Tumor, Leukemia Trial in Paris (Solid tumor and CT DNA)

Recruiting
  • Solid Tumor
  • Leukemia
  • Solid tumor and CT DNA
  • Paris, Villejuif, France
    Gustave Roussy
Jan 19, 2023

Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
May 3, 2023

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

Completed
Has Results
  • Pancreatic Cancer
  • +2 more
  • AMG820 and pembrolizumab
  • Atlanta, Georgia
  • +14 more
Jan 18, 2023